Back to User profile » Dr Vivek Subbiah
Paper published by Dr Vivek Subbiah:
Clinical Trial Report
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies
Piha-Paul SA, Dumbrava EE, Nair BC, Xiong W, Xu L, Mostorino R, Subbiah V, Tannir N, Fu S, Naing A, Janku F, Karp DD, Patel S, Daw NC, Hong D, Meric-Bernstam F, Zinner R
OncoTargets and Therapy 2021, 14:3037-3049
Published Date: 7 May 2021